Загрузка...
Comparison of the Outcome of Patients Protected by the Wearable Cardioverter Defibrillator (WCD) for <90 Wear Days versus ≥90 Wear Days
Background/Aim: The wearable cardioverter/defibrillator (WCD) is recommended to prevent sudden cardiac death (SCD). Guidelines suggest a 90 days’ period, but prolongation of WCD wear time until increasing the ejection fraction (≥35%) might be suggested. Patients and Methods: A cohort of 153 patients...
Сохранить в:
| Опубликовано в: : | In Vivo |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
International Institute of Anticancer Research
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7811610/ https://ncbi.nlm.nih.gov/pubmed/33144474 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12205 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|